“But we had a big fat hurdle ahead that not nece
Post# of 148126
(Total Views: 748)
Posted On: 03/30/2021 6:18:15 PM
“But we had a big fat hurdle ahead that not necessary wanted to help us ...
No need to elaborate further.”
NP was that hurdle and still is a hurdle. But he’s like one of those steeple chase hurdles with water on the other side.
NP rushed the CD12 protocol. Based on PRs, the CD12 protocol was submitted after only a handful of the initial EINDs had been injected. Therefore, there wasn’t much data to support the argument that additional doses or IV infusion was needed. And if you recall the initial protocol, NP, Dr. Jay, and the others at CYDY set the primary endpoint as 14 day mortality, which proves they didn’t believe more than 2 doses were needed. Had they waited 2-3 weeks, they would’ve had data from 20-40 EIND patients, which could’ve been used to develop a better CD12 protocol development.
No need to elaborate further.”
NP was that hurdle and still is a hurdle. But he’s like one of those steeple chase hurdles with water on the other side.
NP rushed the CD12 protocol. Based on PRs, the CD12 protocol was submitted after only a handful of the initial EINDs had been injected. Therefore, there wasn’t much data to support the argument that additional doses or IV infusion was needed. And if you recall the initial protocol, NP, Dr. Jay, and the others at CYDY set the primary endpoint as 14 day mortality, which proves they didn’t believe more than 2 doses were needed. Had they waited 2-3 weeks, they would’ve had data from 20-40 EIND patients, which could’ve been used to develop a better CD12 protocol development.
(7)
(6)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼